Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures

By Héloïse Ragelle, F. Danhier, V. Préat, Robert Langer, Daniel G. Anderson. Expert Opinion on Drug Delivery, 2017

315 citations recorded by the source corpus.

Subfields: Biomaterials, Biomedical Engineering, Materials Chemistry

View Paper: https://www.semanticscholar.org/paper/91afcabf8365e0e38ae350e66c1583b408bbf577

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. T. Vandamme
2. N. Anton

In Biomedical Engineering

1. N. Anton

In Materials Chemistry

1. N. Anton
2. T. Vandamme

Citations in the corpus

• An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites (2019, background): “Though some formulations have already been developed in the market during the last decade,([4]) there still no universal platform is suitable for the delivery of all kinds of drugs, that is to say the theory ‘one size fits all’ does not apply.”